Content List
Back to Content List
Abstracts
Page 46
of 477
ADALIMUMAB FOR PATIENT'S WITH CROHN'S PERIANAL FISTULAS
Content Type: Abstracts
Author: Leah R. Griggs, MD, Paul Wise, MD, Alan Herline, MD, Roberta Muldoon, MD, David A. Schwartz, MD
Event: 2006 ACG Abstracts
Adalimumab for Patients with Ulcerative Colitis Who have Lost Response or are Intolerant of Infliximab: Initial Response Rates are High, But the Response May Not be Durable
Content Type: Abstracts
Author: Aparajita Singh, Uma Mahadevan, Eugene F. Yen, Jonathan Terdiman
Event: 2009 ACG Abstracts
Adalimumab Improves Work Productivity and Reduces Indirect Costs with Patients with Moderate to Severe Crohn's Disease: A Meta-analysis
Content Type: Abstracts
Author: David Binion, Edouard Louis, Andrew Yu, Arielle G. Bensimon, Eric Q. Wu, Jingdong Chao, Parvez Mulani
Event: 2009 ACG Abstracts
Adalimumab in Crohn's Disease Patients to Maintain Surgically-induced Remission: Can Fecal Calprotectin Predict Postoperative Recurrence?
Content Type: Abstracts
Author: Ignacio Fdez-Blanco, Barbara Martinez, Rosa Codoceo, Jose Maria Monturiol, Miguel Garcia-Montes, Carlos Cara
Event: 2009 ACG Abstracts
ADALIMUMAB INDUCED AND MAINTAINED CLINICAL REMISSION IN PATIENTS WITH CROHN'S DISEASE INDEPENDENT OF BASELINE CRP CONCENTRATION: SUBANALYSIS OF THE CHARM STUDY
Content Type: Abstracts
Author: Robert A. Enns, MD, S. Schreiber, MD, J.F. Colombel, MD, W.J. Sandborn, MD, P. Rutgeerts, MD, S.B. Hanauer, MD, J.D. Kent, MD, P.F. Pollack, MD
Event: 2006 ACG Abstracts
ADALIMUMAB IS EFFECTIVE IN PATIENTS WITH FISTULIZING CROHN'S DISEASE WHO WERE PRIMARY NONRESPONDERS TO INFLIXIMAB TREATMENT
Content Type: Abstracts
Author: Simon Lichtiger, MD, David Binion, MD, Douglas Wolf, MD, Daniel Present, MD, Kathleen Lomax, MD, Shuvobrata Rafiq, MA, Fred Holdbrook, PhD
Event: 2008 ACG Abstracts
ADALIMUMAB MAINTAINS CLINICAL REMISSION AND RESPONSE IN PATIENTS WITH ACTIVE CROHN'S DISEASE: RESULTS OF THE CHARM TRIAL
Content Type: Abstracts
Author: William J. Sandborn, MD, J.F. Colombel, MD, P. Rutgeerts, MD, R. Enns, MD, S.B. Hanauer, MD, R. Panaccione, MD, S. Schreiber, MD, K.G. Lomax, MD, P.F. Pollack, MD
Event: 2006 ACG Abstracts
ADALIMUMAB MAINTENANCE THERAPY IS ASSOCIATED WITH A REDUCED RISK OF MAJOR SURGERY
Content Type: Abstracts
Author: Stefan Schreiber, MD, Brian Feagan, MD, William Sandborn, MD, Jean Fred Colombel, MD, Kathleen Lomax, MD, Parvez Mulani, PhD, Jingdong Chao, PhD
Event: 2008 ACG Abstracts
ADALIMUMAB MAINTENANCE THERAPY IS COST EFFECTIVE FOR MAINTAINING REMISSION IN PATIENTS WITH CROHN'S DISEASE
Content Type: Abstracts
Author: Brian Feagan, MD, Edward Loftus, MD, Scott Johnson, PhD, Eric Wu, PhD, Andrew Yu, PhD, Jingdong Chao, PhD, Parvez Mulani, PhD
Event: 2008 ACG Abstracts
ADALIMUMAB RAPIDLY INDUCES CLINICAL REMISSION AND RESPONSE IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE WHO HAD SECONDARY FAILURE TO INFLIXIMAB THERAPY: RESULTS OF THE GAIN STUDY
Content Type: Abstracts
Author: William J. Sandborn, MD, P. Rutgeerts, MD, R.A. Enns, MD, S.B. Hanauer, MD, J.F. Colombel, MD, R. Panaccione, MD, J.D. Kent, MD, P.F. Pollack, MD
Event: 2006 ACG Abstracts
[<< Prev]
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
[Next >>]
American College of Gastroenterology P.O. Box 342260 Bethesda, MD 20827-2260 (301) 263-9000
©2007 American College of Gastroenterology | Privacy Policy | Copyright Policy